Global Endorphins Market Research Report 2021
Table of Content
1 Endorphins Market Overview
- 1.1 Product Overview and Scope of Endorphins
- 1.2 Endorphins Segment by Type
- 1.2.1 Global Endorphins Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 Alpha-Endorphins
- 1.2.3 Beta-Endorphins
- 1.2.4 Gamma-Endorphins
- 1.2.5 Sigma-Endorphins
- 1.3 Endorphins Segment by Application
- 1.3.1 Endorphins Sales Comparison by Application: (2021-2027)
- 1.3.2 Institutional Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Global Endorphins Market Size Estimates and Forecasts
- 1.4.1 Global Endorphins Revenue 2016-2027
- 1.4.2 Global Endorphins Sales 2016-2027
- 1.4.3 Endorphins Market Size by Region: 2016 Versus 2021 Versus 2027
2 Endorphins Market Competition by Manufacturers
- 2.1 Global Endorphins Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Endorphins Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Endorphins Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Endorphins Manufacturing Sites, Area Served, Product Type
- 2.5 Endorphins Market Competitive Situation and Trends
- 2.5.1 Endorphins Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Endorphins Players Market Share by Revenue
- 2.5.3 Global Endorphins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endorphins Retrospective Market Scenario by Region
- 3.1 Global Endorphins Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.2 Global Endorphins Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.3 North America Endorphins Market Facts & Figures by Country
- 3.3.1 North America Endorphins Sales by Country
- 3.3.2 North America Endorphins Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Endorphins Market Facts & Figures by Country
- 3.4.1 Europe Endorphins Sales by Country
- 3.4.2 Europe Endorphins Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Endorphins Market Facts & Figures by Region
- 3.5.1 Asia Pacific Endorphins Sales by Region
- 3.5.2 Asia Pacific Endorphins Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Endorphins Market Facts & Figures by Country
- 3.6.1 Latin America Endorphins Sales by Country
- 3.6.2 Latin America Endorphins Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Endorphins Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Endorphins Sales by Country
- 3.7.2 Middle East and Africa Endorphins Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Endorphins Historic Market Analysis by Type
- 4.1 Global Endorphins Sales Market Share by Type (2016-2021)
- 4.2 Global Endorphins Revenue Market Share by Type (2016-2021)
- 4.3 Global Endorphins Price by Type (2016-2021)
5 Global Endorphins Historic Market Analysis by Application
- 5.1 Global Endorphins Sales Market Share by Application (2016-2021)
- 5.2 Global Endorphins Revenue Market Share by Application (2016-2021)
- 5.3 Global Endorphins Price by Application (2016-2021)
6 Key Companies Profiled
- 6.1 Assertio Therapeutics Inc.
- 6.1.1 Assertio Therapeutics Inc. Corporation Information
- 6.1.2 Assertio Therapeutics Inc. Description and Business Overview
- 6.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 Assertio Therapeutics Inc. Product Portfolio
- 6.1.5 Assertio Therapeutics Inc. Recent Developments/Updates
- 6.2 Cipher Pharmaceuticals Inc.
- 6.2.1 Cipher Pharmaceuticals Inc. Corporation Information
- 6.2.2 Cipher Pharmaceuticals Inc. Description and Business Overview
- 6.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 Cipher Pharmaceuticals Inc. Product Portfolio
- 6.2.5 Cipher Pharmaceuticals Inc. Recent Developments/Updates
- 6.3 Endo International Plc
- 6.3.1 Endo International Plc Corporation Information
- 6.3.2 Endo International Plc Description and Business Overview
- 6.3.3 Endo International Plc Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 Endo International Plc Product Portfolio
- 6.3.5 Endo International Plc Recent Developments/Updates
- 6.4 Egalet Corp.
- 6.4.1 Egalet Corp. Corporation Information
- 6.4.2 Egalet Corp. Description and Business Overview
- 6.4.3 Egalet Corp. Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Egalet Corp. Product Portfolio
- 6.4.5 Egalet Corp. Recent Developments/Updates
- 6.5 Lannett Co. Inc.
- 6.5.1 Lannett Co. Inc. Corporation Information
- 6.5.2 Lannett Co. Inc. Description and Business Overview
- 6.5.3 Lannett Co. Inc. Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 Lannett Co. Inc. Product Portfolio
- 6.5.5 Lannett Co. Inc. Recent Developments/Updates
- 6.6 Pfizer
- 6.6.1 Pfizer Corporation Information
- 6.6.2 Pfizer Description and Business Overview
- 6.6.3 Pfizer Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Pfizer Product Portfolio
- 6.6.5 Pfizer Recent Developments/Updates
- 6.7 Johnson & Johnson
- 6.6.1 Johnson & Johnson Corporation Information
- 6.6.2 Johnson & Johnson Description and Business Overview
- 6.6.3 Johnson & Johnson Endorphins Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Johnson & Johnson Product Portfolio
- 6.7.5 Johnson & Johnson Recent Developments/Updates
7 Endorphins Manufacturing Cost Analysis
- 7.1 Endorphins Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Endorphins
- 7.4 Endorphins Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Endorphins Distributors List
- 8.3 Endorphins Customers
9 Endorphins Market Dynamics
- 9.1 Endorphins Industry Trends
- 9.2 Endorphins Growth Drivers
- 9.3 Endorphins Market Challenges
- 9.4 Endorphins Market Restraints
10 Global Market Forecast
- 10.1 Endorphins Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Endorphins by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Endorphins by Type (2022-2027)
- 10.2 Endorphins Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Endorphins by Application (2022-2027)
- 10.2.2 Global Forecasted Revenue of Endorphins by Application (2022-2027)
- 10.3 Endorphins Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Endorphins by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Endorphins by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Description
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson